HIV-positive TB patients on ART (antiretroviral therapy) in Americas (WHO region)
Americas (WHO region): HIV-positive TB patients on ART (antiretroviral therapy) was 68.0% in 2024. ▼ Falling
HIV-positive TB patients on ART (antiretroviral therapy) in Americas (WHO region), 2003–2024
Source: World Health Organization, Global Health Observatory.
Analysis
In 2024, hiv-positive tb patients on art (antiretroviral therapy) in Americas (WHO region) stood at 68.0%.
The figure is up 3.0% on the previous year and up 4.6% over ten years.
Over the whole period, hiv-positive tb patients on art (antiretroviral therapy) in Americas (WHO region) peaked at 92.0% in 2003 and was at its lowest, 60.0%, in 2013.
The long-run direction has been consistently falling across the 22 years of available data.
HIV-positive TB patients on ART (antiretroviral therapy) in Americas (WHO region), year by year
| Year | Value | Change |
|---|---|---|
| 2003 | 92.0% | — |
| 2004 | 81.0% | -12.0% |
| 2005 | 81.0% | +0.0% |
| 2006 | 91.0% | +12.3% |
| 2007 | 66.0% | -27.5% |
| 2008 | 67.0% | +1.5% |
| 2009 | 63.0% | -6.0% |
| 2010 | 65.0% | +3.2% |
| 2011 | 68.0% | +4.6% |
| 2012 | 77.0% | +13.2% |
| 2013 | 60.0% | -22.1% |
| 2014 | 65.0% | +8.3% |
| 2015 | 60.0% | -7.7% |
| 2016 | 65.0% | +8.3% |
| 2017 | 62.0% | -4.6% |
| 2018 | 64.0% | +3.2% |
| 2019 | 63.0% | -1.6% |
| 2020 | 65.0% | +3.2% |
| 2021 | 66.0% | +1.5% |
| 2022 | 67.0% | +1.5% |
| 2023 | 66.0% | -1.5% |
| 2024 | 68.0% | +3.0% |
Biggest year-on-year movements
Years where HIV-positive TB patients on ART (antiretroviral therapy) in Americas (WHO region) changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.
| Year | Change | From | To |
|---|---|---|---|
| 2007 | -27.5% | 91.0% | 66.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 77.3% | 63.0% | 92.0% | 7 |
| 2010s | 64.9% | 60.0% | 77.0% | 10 |
| 2020s | 66.4% | 65.0% | 68.0% | 5 |
More health data for Americas (WHO region)
- Pertussis - number of reported cases, gaps filled 24,640 (2025)
- Neonatal tetanus - number of reported cases, gaps filled 23 (2025)
- Total tetanus - number of reported cases, gaps filled 385 (2025)
- Diphtheria - number of reported cases, gaps filled 72 (2025)
- Measles - number of reported cases, gaps filled 12,380 (2025)
- Number of under-five deaths, annual growth rate -2.83 % change on previous year (2024)
- Number of neonatal deaths, annual growth rate -3.22 % change on previous year (2024)
- Number of infant deaths, annual growth rate -2.68 % change on previous year (2024)
- Measles - number of reported cases, annual growth rate 22.22 % change on previous year (2024)
- Pertussis - number of reported cases, annual growth rate -20.67 % change on previous year (2025)
Frequently asked questions
- What is hiv-positive tb patients on art (antiretroviral therapy) in Americas (WHO region)?
- Hiv-positive tb patients on art (antiretroviral therapy) in Americas (WHO region) was 68.0% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest hiv-positive tb patients on art (antiretroviral therapy) recorded in Americas (WHO region)?
- The highest recorded value was 92.0% in 2003.
- What is the lowest hiv-positive tb patients on art (antiretroviral therapy) recorded in Americas (WHO region)?
- The lowest recorded value was 60.0% in 2013.
- How does Americas (WHO region) rank for hiv-positive tb patients on art (antiretroviral therapy)?
- Americas (WHO region) ranks 10th out of 11 groups with data for 2024.
- Is hiv-positive tb patients on art (antiretroviral therapy) rising or falling in Americas (WHO region)?
- Over the last ten years it is up 4.6%. The long-run trend across the full record is falling.
- Where does this Americas (WHO region) data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 22 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).